12.10.20 -- New Podcast Episodes: 2021 Trends For Biotech, Modulation Of The Microbiome And Biopharma Financing

Check out the latest from Business of Biotech, Bioprocess with the Bozenhardts, and Life Science Connect. As a member of the Life Science Connect community you have access to content beyond our weekly newsletters, including our podcast series. Don’t forget to subscribe so that you never miss an episode!

Dr. Bernat Olle discusses the pioneering work his company, Vedanta Biosciences, is doing to modulate the immune system and provide colonization resistance against infectious pathogens — particularly those contracted during hospital stays. Learn about a company pioneering the exploration of immune-regulating and immune-potentiating bacteria.

Smital Shah brings a trifecta of chemical engineering, consulting, and finance experience earned at heavyweight companies JP Morgan, Leerink, and Gilead to her role at clinical-stage RNA therapy biotech ProQR Therapeutics. We sat down for a deep conversation on the recipe for successful business and finance operations in an emerging biopharma organization.

Herman and Erich Bozenhardt have a collective 55 years of bioprocess facilities design and equipment experience, and they’re here to share it all in our fresh Bioprocess with the Bozenhardts podcast series.

Today’s guest, Matt Pillar, not only hosts two of his own podcasts, but is our chief editor for BioProcess Online. Matt gives a peek into what trends he wrote about for the Life Science Leader outlook issue and he talks about what’s next for his Business of Biotech podcast.